Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

Cited In for PubMed (Select 8957086)

1.

HMGA proteins as modulators of chromatin structure during transcriptional activation.

Ozturk N, Singh I, Mehta A, Braun T, Barreto G.

Front Cell Dev Biol. 2014 Mar 6;2:5. doi: 10.3389/fcell.2014.00005. eCollection 2014. Review.

2.

A novel anti-proliferative role of HMGA2 in induction of apoptosis through caspase 2 in primary human fibroblast cells.

Shi X, Tian B, Ma W, Zhang N, Qiao Y, Li X, Zhang Y, Huang B, Lu J.

Biosci Rep. 2015 Jan 14;35(1). pii: e00169. doi: 10.1042/BSR20140112.

3.

HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.

Esposito F, De Martino M, Petti MG, Forzati F, Tornincasa M, Federico A, Arra C, Pierantoni GM, Fusco A.

Oncotarget. 2014 Sep 30;5(18):8341-54.

4.

Genome-wide association studies identify the loci for 5 exterior traits in a Large White × Minzhu pig population.

Wang L, Zhang L, Yan H, Liu X, Li N, Liang J, Pu L, Zhang Y, Shi H, Zhao K, Wang L.

PLoS One. 2014 Aug 4;9(8):e103766. doi: 10.1371/journal.pone.0103766. eCollection 2014.

5.

Microarray comparison of the gene expression profiles in the adult vs. embryonic day 14 rat liver.

Zheng J, Yu S, Jiang Z, Shi C, Li J, DU X, Wang H, Jiang J.

Biomed Rep. 2014 Sep;2(5):664-670. Epub 2014 Jun 25.

6.

Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype.

Federico A, Forzati F, Esposito F, Arra C, Palma G, Barbieri A, Palmieri D, Fedele M, Pierantoni GM, De Martino I, Fusco A.

Biol Open. 2014 Apr 11;3(5):372-8. doi: 10.1242/bio.20146759.

7.

Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.

Hombach-Klonisch S, Natarajan S, Thanasupawat T, Medapati M, Pathak A, Ghavami S, Klonisch T.

Front Endocrinol (Lausanne). 2014 Mar 25;5:37. doi: 10.3389/fendo.2014.00037. eCollection 2014. Review.

8.

Correlated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental models.

Klemke M, Müller MH, Wosniok W, Markowski DN, Nimzyk R, Helmke BM, Bullerdiek J.

PLoS One. 2014 Feb 7;9(2):e88126. doi: 10.1371/journal.pone.0088126. eCollection 2014.

9.

Hitting the bull's eye: targeting HMGA1 in cancer stem cells.

Yanagisawa BL, Resar LM.

Expert Rev Anticancer Ther. 2014 Jan;14(1):23-30. doi: 10.1586/14737140.2013.859988.

10.

A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.

Sompallae R, Hofmann O, Maher CA, Gedye C, Behren A, Vitezic M, Daub CO, Devalle S, Caballero OL, Carninci P, Hayashizaki Y, Lawlor ER, Cebon J, Hide W.

Front Genet. 2013 Oct 29;4:209. doi: 10.3389/fgene.2013.00209. eCollection 2013.

11.

Characterization of the Stoichiometry of HMGA1/DNA Complexes.

Watanabe M, Ni S, Lindenberger AL, Cho J, Tinch SL, Kennedy MA.

Open Biochem J. 2013 Sep 4;7:73-81. doi: 10.2174/1874091X01307010073. eCollection 2013.

12.

Expression and functional characterization of Xhmg-at-hook genes in Xenopus laevis.

Macrì S, Sgarra R, Ros G, Maurizio E, Zammitti S, Milani O, Onorati M, Vignali R, Manfioletti G.

PLoS One. 2013 Jul 25;8(7):e69866. doi: 10.1371/journal.pone.0069866. Print 2013.

13.

Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis.

Qu Y, Wang Y, Ma J, Zhang Y, Meng N, Li H, Wang Y, Wei W.

PLoS One. 2013 Jul 23;8(7):e68724. doi: 10.1371/journal.pone.0068724. Print 2013.

14.

High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria.

Esposito F, Tornincasa M, Federico A, Chiappetta G, Pierantoni GM, Fusco A.

Cell Death Dis. 2012 Aug 30;3:e383. doi: 10.1038/cddis.2012.126. Retraction in: Cell Death Dis. 2014;5:e1206.

15.

The hallmarks of cancer: a long non-coding RNA point of view.

Gutschner T, Diederichs S.

RNA Biol. 2012 Jun;9(6):703-19. doi: 10.4161/rna.20481. Epub 2012 Jun 1. Review.

16.

HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.

Belton A, Gabrovsky A, Bae YK, Reeves R, Iacobuzio-Donahue C, Huso DL, Resar LM.

PLoS One. 2012;7(1):e30034. doi: 10.1371/journal.pone.0030034. Epub 2012 Jan 20.

17.

HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.

Schuldenfrei A, Belton A, Kowalski J, Talbot CC Jr, Di Cello F, Poh W, Tsai HL, Shah SN, Huso TH, Huso DL, Resar LM.

BMC Genomics. 2011 Nov 4;12:549. doi: 10.1186/1471-2164-12-549.

18.

HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines.

Watanabe M, Sheriff S, Lewis KB, Tinch SL, Cho J, Balasubramaniam A, Kennedy MA.

Cancer Lett. 2012 Feb 1;315(1):18-27. doi: 10.1016/j.canlet.2011.10.005. Epub 2011 Oct 10.

19.

Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein.

Mansueto G, Forzati F, Ferraro A, Pallante P, Bianco M, Esposito F, Iaccarino A, Troncone G, Fusco A.

Genes Cancer. 2010 Mar;1(3):210-24. doi: 10.1177/1947601910366860.

20.

Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion.

Wei JJ, Wu X, Peng Y, Shi G, Basturk O, Yang X, Daniels G, Osman I, Ouyang J, Hernando E, Pellicer A, Rhim JS, Melamed J, Lee P.

Clin Cancer Res. 2011 Mar 15;17(6):1297-305. doi: 10.1158/1078-0432.CCR-10-0993. Epub 2010 Dec 7. Erratum in: Clin Cancer Res. 2011 Aug 15;17(16):5523. Olca, Basturk [corrected to Basturk, Olca].

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk